Rachel G. Liao - Concepedia

Author

Rachel G. Liao

Also Known As

Daniella Coker, Liao, Rachel G., Mari E. K. Niemi, Masahiro Kanai, R G Liao, R. Liao, R.G. Liao, Rachel G Liao, Rachel G. Liao, Rachel Liao

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Broad Institute Dana-Farber Cancer Institute Harvard University Brigham and Women's Hospital McGill University

About

Rachel G. Liao is an author at Broad Institute specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	805
2	Cell Biology	4	4	538
3	Engineering	1	1	264
4	Natural Sciences	1	1	175
5	Biomolecular Engineering	1	1	175

Rachel G. Liao

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of <i>ERBB2</i> Heidi Greulich, Bethany Kaplan, Philipp Mertins, Proceedings of the National Academy of Sciences Systems BiologySignal TransductionEngineeringTransformation AssaysSignaling Pathway	2012	264
BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2 Melissa Cline, Rachel G. Liao, Michael T. Parsons, PLoS Genetics	2018	205
Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors Li Tan, Jun Wang, Junko Tanizaki, Proceedings of the National Academy of Sciences Covalent InhibitorsFgfr InhibitorsHuman Fgf ReceptorsMolecular BiologyPharmacotherapy	2014	175
Inhibitor-Sensitive FGFR2 and FGFR3 Mutations in Lung Squamous Cell Carcinoma Rachel G. Liao, Joonil Jung, Jeremy H. Tchaicha, Cancer Research Family MembersFgfr InhibitorsMedicineInhibitor-sensitive Fgfr2Pathology	2013	167
Facilitating a culture of responsible and effective sharing of cancer genome data Lillian L. Siu, Mark Lawler, David Haussler, Nature Medicine Systems BiologyHealth InformaticsFunctional GenomicsTranslational BioinformaticsGenetics	2016	92
Ligand-associated ERBB2/3 activation confers acquired resistance to FGFR inhibition in FGFR3-dependent cancer cells Jun Wang, Oliver R. Mikse, Rachel G. Liao, Oncogene Fgfr InhibitionMedicineReceptor Tyrosine KinaseCell BiologyFgfr3-dependent Cancer Cells	2014	69
A Loss-of-Function Splice Acceptor Variant in <i>IGF2</i> Is Protective for Type 2 Diabetes Josep M. Mercader, Rachel G. Liao, Avery Davis Bell, Diabetes	2017	63
RAS–MAPK Reactivation Facilitates Acquired Resistance in <i>FGFR1</i> -Amplified Lung Cancer and Underlies a Rationale for Upfront FGFR–MEK Blockade Bruno Bockorny, Maria Rusan, Wankun Chen, Molecular Cancer Therapeutics	2018	60
Targeted Therapy for Squamous Cell Lung Cancer Rachel G. Liao, Hideo Watanabe, Matthew Meyerson, Lung Cancer Management	2012	49
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues Matteo D’Antonio, Jennifer Nguyen, Timothy D. Arthur, Cell Reports	2021	46

Page 1